Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s interface/display revision was updated from **v3.5.2** to **v3.5.3**, indicating a site version change rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:36:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Updated the listed location from Padua, PD, Italy, 35128 to Padova, PD, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T21:53:03.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T08:35:44.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T04:44:54.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added a page revision label (Revision: v3.4.2) and removed an older government-funding notice; these are administrative updates that do not affect the study data or access to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T16:55:01.000Z thumbnail image

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.